<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7298161\results\search\disease\results.xml">
  <result pre="the PMC Open Access Subset for unrestricted research re-use and" exact="secondary" post="analysis in any form or by any means with"/>
  <result pre="a global pandemic. Abstract Since the outbreak of novel coronavirus" exact="pneumonia" post="(COVID-19) in December 2019, more than 2,500,000 people worldwide"/>
  <result pre="further understanding of SARS-CoV-2 virus, new drugs targeting specific SARS-CoV-2" exact="viral" post="components arise and investigations on these novel anti-SARS-CoV-2 agents"/>
  <result pre="anti-SARS-CoV-2 agents are also reviewed. Keywords SARS-CoV-2 COVID-19 novel coronavirus" exact="pneumonia" post="therapeutic drugs anti-SARS-CoV-2 agents favipiravir hydroxychloroquine traditional Chinese medicine"/>
  <result pre="cause, whole-genome sequencing of samples from patients with this unexplained" exact="pneumonia" post="revealed a beta-coronavirus that had never been seen before,"/>
  <result pre="International Committee on Taxonomy of Viruses introduced the name â€œsevere" exact="acute" post="respiratory syndrome coronavirus 2â€� (SARS-CoV-2) to refer to the"/>
  <result pre="Committee on Taxonomy of Viruses introduced the name â€œsevere acute" exact="respiratory" post="syndrome coronavirus 2â€� (SARS-CoV-2) to refer to the virus,"/>
  <result pre="on Taxonomy of Viruses introduced the name â€œsevere acute respiratory" exact="syndrome" post="coronavirus 2â€� (SARS-CoV-2) to refer to the virus, and"/>
  <result pre="refer to the virus, and the WHO named the related" exact="pneumonia" post="coronavirus pneumonia (COVID-19). This article will go through basic"/>
  <result pre="the virus, and the WHO named the related pneumonia coronavirus" exact="pneumonia" post="(COVID-19). This article will go through basic virology of"/>
  <result pre="a 3â€²Â untranslated region [3]. ORF1a/b occupy two-thirds of the" exact="viral" post="genome, and they encode two polyproteins, pp1a and pp1ab"/>
  <result pre="glycoproteins protruding from the envelope and is closely related to" exact="virus infection" post="of cells [9]. There are multiple sequence segments in"/>
  <result pre="protruding from the envelope and is closely related to virus" exact="infection" post="of cells [9]. There are multiple sequence segments in"/>
  <result pre="membrane (M), are incorporated into the virion. Nucleoprotein encapsulates the" exact="viral" post="(+) RNA genome in the form of a spiral"/>
  <result pre="envelopeÂ to prevent degradation. Accessory proteins do not participate in" exact="viral" post="replication, but they interfere with the host innate immune"/>
  <result pre="membrane or with the endosome membrane. After membrane fusion, the" exact="viral" post="RNA genome is released into the cytoplasm, and the"/>
  <result pre="into different structural proteins. The newly formed structural protein and" exact="viral" post="genomic RNA combine to form a nucleocapsid. The viral"/>
  <result pre="and viral genomic RNA combine to form a nucleocapsid. The" exact="viral" post="particles bud into the ERâ€&quot;Golgi intermediate compartment (ERGIC), and"/>
  <result pre="form a nucleocapsid. The viral particles bud into the ERâ€&quot;Golgi" exact="intermediate" post="compartment (ERGIC), and then the primary virion is released"/>
  <result pre="bud into the ERâ€&quot;Golgi intermediate compartment (ERGIC), and then the" exact="primary" post="virion is released from the infected cells [10].Â Â"/>
  <result pre="of COVID-19 [11]. Among those COVID-19 treatment-related clinical trials, a" exact="total" post="of 155 registered COVID-19 treatment drug-related interventional studies were"/>
  <result pre="patients. With so many clinical trials registered in such a" exact="short" post="period of time, we can see that China has"/>
  <result pre="trials can create the problem of squeezing each other for" exact="limited" post="medical resources or even wasting them. This phenomenon and"/>
  <result pre="of which are nucleotide analogs and protease inhibitors against other" exact="viral" post="pathogens, including influenza virus, HIV and HCV. Comprehensive information"/>
  <result pre="clinical trials. Category Drug name Approved indication Mechanism Biomacro-molecule Tocilizumab" exact="Rheumatoid arthritis" post="IL-6R antibody Type I interferon (include IFN-Î± &amp;amp; IFN-Î²)"/>
  <result pre="trials. Category Drug name Approved indication Mechanism Biomacro-molecule Tocilizumab Rheumatoid" exact="arthritis" post="IL-6R antibody Type I interferon (include IFN-Î± &amp;amp; IFN-Î²)"/>
  <result pre="name Approved indication Mechanism Biomacro-molecule Tocilizumab Rheumatoid arthritis IL-6R antibody" exact="Type I" post="interferon (include IFN-Î± &amp;amp; IFN-Î²) Hairy cell leukemia, melanoma,"/>
  <result pre="arthritis IL-6R antibody Type I interferon (include IFN-Î± &amp;amp; IFN-Î²)" exact="Hairy cell leukemia," post="melanoma, AIDS-related Kaposiâ€™s sarcoma Immune modulation Thymosin a1 T"/>
  <result pre="(include IFN-Î± &amp;amp; IFN-Î²) Hairy cell leukemia, melanoma, AIDS-related Kaposiâ€™s" exact="sarcoma" post="Immune modulation Thymosin a1 T cell defect, autoimmunity disease"/>
  <result pre="Kaposiâ€™s sarcoma Immune modulation Thymosin a1 T cell defect, autoimmunity" exact="disease" post="T cell stimulation rhG-CSF Leukopenia CSF receptor Chemical Agent"/>
  <result pre="a1 T cell defect, autoimmunity disease T cell stimulation rhG-CSF" exact="Leukopenia" post="CSF receptor Chemical Agent Lopinavir/ritonavir HIV HIV-1 protease inhibitor"/>
  <result pre="endonuclease inhibitor Arbidol Flu Virion entry inhibitor Poly (I:C) Injection" exact="Viral" post="infection Immune modulation Carrimycin Bacteria infection Peptide acyltransferase inhibitor"/>
  <result pre="inhibitor Arbidol Flu Virion entry inhibitor Poly (I:C) Injection Viral" exact="infection" post="Immune modulation Carrimycin Bacteria infection Peptide acyltransferase inhibitor Dihydroartemisinine/Piperaquine"/>
  <result pre="inhibitor Poly (I:C) Injection Viral infection Immune modulation Carrimycin Bacteria" exact="infection" post="Peptide acyltransferase inhibitor Dihydroartemisinine/Piperaquine Malaria Multiple targets Chloroquineb Malaria"/>
  <result pre="infection Immune modulation Carrimycin Bacteria infection Peptide acyltransferase inhibitor Dihydroartemisinine/Piperaquine" exact="Malaria" post="Multiple targets Chloroquineb Malaria Heme biocrystallization inhibitor Suramin Trypanosomes"/>
  <result pre="Immune modulation Carrimycin Bacteria infection Peptide acyltransferase inhibitor Dihydroartemisinine/Piperaquine Malaria" exact="Multiple" post="targets Chloroquineb Malaria Heme biocrystallization inhibitor Suramin Trypanosomes infection"/>
  <result pre="Bacteria infection Peptide acyltransferase inhibitor Dihydroartemisinine/Piperaquine Malaria Multiple targets Chloroquineb" exact="Malaria" post="Heme biocrystallization inhibitor Suramin Trypanosomes infection Multiple targets Ruxolitinib"/>
  <result pre="Malaria Multiple targets Chloroquineb Malaria Heme biocrystallization inhibitor Suramin Trypanosomes" exact="infection" post="Multiple targets Ruxolitinib Myelofibrosis JAK1/JAK2 signaling inhibition Leflunomide Rheumatoid"/>
  <result pre="Multiple targets Chloroquineb Malaria Heme biocrystallization inhibitor Suramin Trypanosomes infection" exact="Multiple" post="targets Ruxolitinib Myelofibrosis JAK1/JAK2 signaling inhibition Leflunomide Rheumatoid arthritis"/>
  <result pre="Trypanosomes infection Multiple targets Ruxolitinib Myelofibrosis JAK1/JAK2 signaling inhibition Leflunomide" exact="Rheumatoid arthritis" post="Pyrimidine synthesis inhibitor Tranilast Bronchial asthma, Allergic disorders Hematopoietic"/>
  <result pre="infection Multiple targets Ruxolitinib Myelofibrosis JAK1/JAK2 signaling inhibition Leflunomide Rheumatoid" exact="arthritis" post="Pyrimidine synthesis inhibitor Tranilast Bronchial asthma, Allergic disorders Hematopoietic"/>
  <result pre="inhibition Leflunomide Rheumatoid arthritis Pyrimidine synthesis inhibitor Tranilast Bronchial asthma," exact="Allergic" post="disorders Hematopoietic prostaglandin D synthase inhibitor Ebastine Allergic rhinitis,"/>
  <result pre="Bronchial asthma, Allergic disorders Hematopoietic prostaglandin D synthase inhibitor Ebastine" exact="Allergic" post="rhinitis, Chronic idiopathic urticaria Histamine H1-receptor antagonist Alpha lipoic"/>
  <result pre="Allergic disorders Hematopoietic prostaglandin D synthase inhibitor Ebastine Allergic rhinitis," exact="Chronic" post="idiopathic urticaria Histamine H1-receptor antagonist Alpha lipoic acid Diabetic"/>
  <result pre="Hematopoietic prostaglandin D synthase inhibitor Ebastine Allergic rhinitis, Chronic idiopathic" exact="urticaria" post="Histamine H1-receptor antagonist Alpha lipoic acid Diabetic multiple peripheral"/>
  <result pre="inhibitor Ebastine Allergic rhinitis, Chronic idiopathic urticaria Histamine H1-receptor antagonist" exact="Alpha" post="lipoic acid Diabetic multiple peripheral neuropathy Antioxidant Pirfenidone Idiopathic"/>
  <result pre="idiopathic urticaria Histamine H1-receptor antagonist Alpha lipoic acid Diabetic multiple" exact="peripheral neuropathy" post="Antioxidant Pirfenidone Idiopathic pulmonary fibrosis Collagen synthesis inhibition, Cytokine"/>
  <result pre="urticaria Histamine H1-receptor antagonist Alpha lipoic acid Diabetic multiple peripheral" exact="neuropathy" post="Antioxidant Pirfenidone Idiopathic pulmonary fibrosis Collagen synthesis inhibition, Cytokine"/>
  <result pre="antagonist Alpha lipoic acid Diabetic multiple peripheral neuropathy Antioxidant Pirfenidone" exact="Idiopathic pulmonary fibrosis" post="Collagen synthesis inhibition, Cytokine down-regulation Bismuth potassium citrate Gastric"/>
  <result pre="Alpha lipoic acid Diabetic multiple peripheral neuropathy Antioxidant Pirfenidone Idiopathic" exact="pulmonary" post="fibrosis Collagen synthesis inhibition, Cytokine down-regulation Bismuth potassium citrate"/>
  <result pre="synthesis inhibition, Cytokine down-regulation Bismuth potassium citrate Gastric ulcer Gastric" exact="mucosa" post="protectant Enoxaparin Sodium Injection Venous thromboembolic disease Xa factor"/>
  <result pre="Gastric ulcer Gastric mucosa protectant Enoxaparin Sodium Injection Venous thromboembolic" exact="disease" post="Xa factor inbihitor Glycyrrhizinate Premenstrual syndrome, Viral infections Multiple"/>
  <result pre="Injection Venous thromboembolic disease Xa factor inbihitor Glycyrrhizinate Premenstrual syndrome," exact="Viral" post="infections Multiple targets Glucocorticoid Inflammatory conditions Glucocorticoid receptor aRdRp,"/>
  <result pre="Venous thromboembolic disease Xa factor inbihitor Glycyrrhizinate Premenstrual syndrome, Viral" exact="infections" post="Multiple targets Glucocorticoid Inflammatory conditions Glucocorticoid receptor aRdRp, RNA-dependent"/>
  <result pre="thromboembolic disease Xa factor inbihitor Glycyrrhizinate Premenstrual syndrome, Viral infections" exact="Multiple" post="targets Glucocorticoid Inflammatory conditions Glucocorticoid receptor aRdRp, RNA-dependent RNA"/>
  <result pre="factor inbihitor Glycyrrhizinate Premenstrual syndrome, Viral infections Multiple targets Glucocorticoid" exact="Inflammatory" post="conditions Glucocorticoid receptor aRdRp, RNA-dependent RNA polymerase. Antiviral agents"/>
  <result pre="drugs against COVID-19. For the treatment of patients, isolation and" exact="symptomatic" post="supportive care are currently recommended, including oxygen therapy, water,"/>
  <result pre="of â€œDiagnosis and Treatment Protocol for Novel Coronavirus Pneumoniaâ€�. IFN-Î±" exact="Type I" post="interferons, including IFN-Î± and IFN-Î², have broad-spectrum antiviral effects"/>
  <result pre="[18], and other experts discovered that IFN-Î± can prevent MERS-CoV" exact="infection" post="and effectively inhibit the virus in the early stages"/>
  <result pre="and effectively inhibit the virus in the early stages of" exact="infection" post="[19]. Because it is also a coronavirus and highly"/>
  <result pre="in the United States in 2000 for the treatment of" exact="HIV infection" post="[20]. It is a protease inhibitor and is usually"/>
  <result pre="the United States in 2000 for the treatment of HIV" exact="infection" post="[20]. It is a protease inhibitor and is usually"/>
  <result pre="broad-spectrum antiviral effect [28]. It is used mainly to treat" exact="respiratory" post="syncytial virus infection [29] and in combination with interferon"/>
  <result pre="effect [28]. It is used mainly to treat respiratory syncytial" exact="virus infection" post="[29] and in combination with interferon for hepatitis C"/>
  <result pre="[28]. It is used mainly to treat respiratory syncytial virus" exact="infection" post="[29] and in combination with interferon for hepatitis C"/>
  <result pre="syncytial virus infection [29] and in combination with interferon for" exact="hepatitis C" post="[30]. Ribavirin was widely used in 2003 to treat"/>
  <result pre="with the cell membrane and then block virus entry and" exact="infection" post="[39]. Some studies have found that the spike glycoprotein"/>
  <result pre="virus envelope binds to the ACE2 receptor to mediate SARS-CoV-2" exact="infection" post="[9, 40]. Chloroquine phosphate has been reported to interfere"/>
  <result pre="[13]. Arbidol Arbidol is a non-nucleoside broad-spectrum antiviral drug for" exact="upper" post="respiratory tract infections caused by influenza A and B"/>
  <result pre="Arbidol Arbidol is a non-nucleoside broad-spectrum antiviral drug for upper" exact="respiratory" post="tract infections caused by influenza A and B viruses,"/>
  <result pre="is a non-nucleoside broad-spectrum antiviral drug for upper respiratory tract" exact="infections" post="caused by influenza A and B viruses, and it"/>
  <result pre="interferon, which can prevent influenza virus invasion and treat influenza" exact="virus infection" post="[45]. Some studies have confirmed that arbidol has a"/>
  <result pre="which can prevent influenza virus invasion and treat influenza virus" exact="infection" post="[45]. Some studies have confirmed that arbidol has a"/>
  <result pre="that arbidol has a good effect against SARS-CoV and MERS-CoV" exact="infections" post="[46, 47]. Chinese scientists found in in vitro cell"/>
  <result pre="A and B [52] and can effectively inhibit Ebola virus," exact="yellow fever" post="virus [53], etc. In vitro experiments have shown that"/>
  <result pre="with adenosine triphosphate, leading to delayed chain termination and inhibiting" exact="viral" post="replication and transcription [57]. A number of in vitro"/>
  <result pre="for COVID-19 has been officially launched in China, and a" exact="total" post="of 761 patients are planned to be enrolled in"/>
  <result pre="inflammation, hydroxychloroquine has been used in the clinical treatment of" exact="systemic" post="lupus erythematosus [63]. Hydroxychloroquine has been shown to have"/>
  <result pre="hydroxychloroquine has been used in the clinical treatment of systemic" exact="lupus erythematosus" post="[63]. Hydroxychloroquine has been shown to have anti-SARS-CoV activity"/>
  <result pre="clinical studies have found that after treatment with hydroxychloroquine, the" exact="viral" post="load significantly decreases or even disappears, and azithromycin can"/>
  <result pre="an important role in the treatment of previous outbreaks of" exact="viral" post="infectious diseases, so it has once again received attention"/>
  <result pre="important role in the treatment of previous outbreaks of viral" exact="infectious diseases," post="so it has once again received attention during this"/>
  <result pre="period of diagnosed patients according to the principle of TCM" exact="syndrome" post="differentiation. For example, for patients with fatigue and fever"/>
  <result pre="virus replication and has been used clinically to treat HCV" exact="infection" post="[71]. Glycyrrhizic acid has been reported to inhibit the"/>
  <result pre="Ginsenoside improves human immunity and has a curative effect on" exact="viral infection" post="[77]. Therefore, traditional Chinese medicine can also be used"/>
  <result pre="improves human immunity and has a curative effect on viral" exact="infection" post="[77]. Therefore, traditional Chinese medicine can also be used"/>
  <result pre="Qinggan granules; Lianhua Qingwen capsules (granules); Shufeng Jiedu capsules (granules)" exact="Severe" post="cases Xiyanping injection; Xuebijing injection; Reduning injection; Tanreqing injection;"/>
  <result pre="granules ChiCTR2000029991 Keqing capsules ChiCTR2000029991 Kesuting syrup ChiCTR2000030469 Liushenwan ChiCTR2000030022" exact="Pediatric" post="Huatanzhike granules ChiCTR2000029589 Reduning injection ChiCTR2000030043 Shenfu injection ChiCTR2000029780"/>
  <result pre="cells through endocytosis via the ACE2 receptor on AT2 alveolar" exact="epithelial" post="cells in the lungs [78, 79]. At present, the"/>
  <result pre="protein with protease and phosphatase activity that is involved in" exact="viral" post="replication and IFN antagonism [81]. PLpro of SARS-CoV-2 and"/>
  <result pre="effect of heat clearing and detoxifying, which could help clear" exact="viral" post="respiratory pathogens and relieve symptoms according to TCM theory."/>
  <result pre="of heat clearing and detoxifying, which could help clear viral" exact="respiratory" post="pathogens and relieve symptoms according to TCM theory. Chinese"/>
  <result pre="China Life Sci2020634576032009228 2.ZhangNWangLDengXLiangRSuMHeCet al.Recent advances in the detection of" exact="respiratory" post="virus infection in humansJ Med Virol2020924081731944312 3.ChanJF-WKokK-HZhuZChuHToKK-WYuanSet al.Genomic characterization"/>
  <result pre="Life Sci2020634576032009228 2.ZhangNWangLDengXLiangRSuMHeCet al.Recent advances in the detection of respiratory" exact="virus infection" post="in humansJ Med Virol2020924081731944312 3.ChanJF-WKokK-HZhuZChuHToKK-WYuanSet al.Genomic characterization of the"/>
  <result pre="Sci2020634576032009228 2.ZhangNWangLDengXLiangRSuMHeCet al.Recent advances in the detection of respiratory virus" exact="infection" post="in humansJ Med Virol2020924081731944312 3.ChanJF-WKokK-HZhuZChuHToKK-WYuanSet al.Genomic characterization of the"/>
  <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting WuhanEmerg Microbes Infect.202092213631987001 4.Zhou P, Yang XL,"/>
  <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting WuhanEmerg Microbes Infect.202092213631987001 4.Zhou P, Yang XL,"/>
  <result pre="al. Discovery of a novel coronavirus associated with the recent" exact="pneumonia" post="outbreak in humans and its potential bat origin. bioRxiv"/>
  <result pre="recent insights into emerging coronavirusesNat Rev Microbiol2016145233427344959 11.http://www.chictr.org.cn/searchprojen.aspx. 12.ChanJF-WYuanSKokK-HToKK-WChuHYangJet al.A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
  <result pre="emerging coronavirusesNat Rev Microbiol2016145233427344959 11.http://www.chictr.org.cn/searchprojen.aspx. 12.ChanJF-WYuanSKokK-HToKK-WChuHYangJet al.A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
  <result pre="a family clusterLancet20203955142331986261 13.Diagnosis and Treatment Protocol for Novel Coronavirus" exact="Pneumonia" post="(Trial Version 7). 14.https://www.who.int/emergencies/diseases/novel-coronavirus-2019. 15.Chunxia ZhouJSXuFengqinJiangShanpingAdvance in research on"/>
  <result pre="7). 14.https://www.who.int/emergencies/diseases/novel-coronavirus-2019. 15.Chunxia ZhouJSXuFengqinJiangShanpingAdvance in research on treatment of influenza" exact="viral pneumonia" post="[in Chinese].Chin J Nosocomiol2020303027 16.WangBXFishENThe Yin and Yang of"/>
  <result pre="14.https://www.who.int/emergencies/diseases/novel-coronavirus-2019. 15.Chunxia ZhouJSXuFengqinJiangShanpingAdvance in research on treatment of influenza viral" exact="pneumonia" post="[in Chinese].Chin J Nosocomiol2020303027 16.WangBXFishENThe Yin and Yang of"/>
  <result pre="19.ChanJFYYYeungMLDengWBaoLJiaLet al.Treatment with lopinavir/ritonavir or interferonbeta1b improves outcome of MERS-CoV" exact="infection" post="in a nonhuman primate model of common marmosetJ Infect"/>
  <result pre="23.KimUJWonE-JKeeS-JJungS-IJangH-CCombination therapy with lopinavir/ritonavir, ribavirin and interferon-Î± for Middle East" exact="respiratory" post="syndromeAntivir Ther201621455926492219 24.WuC-YJanJ-TMaS-HKuoC-JJuanH-FChengY-SEet al.Small molecules targeting severe acute respiratory"/>
  <result pre="Middle East respiratory syndromeAntivir Ther201621455926492219 24.WuC-YJanJ-TMaS-HKuoC-JJuanH-FChengY-SEet al.Small molecules targeting severe" exact="acute" post="respiratory syndrome human coronavirusProc Natl Acad Sci U S"/>
  <result pre="East respiratory syndromeAntivir Ther201621455926492219 24.WuC-YJanJ-TMaS-HKuoC-JJuanH-FChengY-SEet al.Small molecules targeting severe acute" exact="respiratory" post="syndrome human coronavirusProc Natl Acad Sci U S A200410110012715226499"/>
  <result pre="respiratory syndromeAntivir Ther201621455926492219 24.WuC-YJanJ-TMaS-HKuoC-JJuanH-FChengY-SEet al.Small molecules targeting severe acute respiratory" exact="syndrome" post="human coronavirusProc Natl Acad Sci U S A200410110012715226499 25.de"/>
  <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell cultureAntimicrobial agents Chemother201458487584 26.CaoBWangYWenDLiuWWangJFanGet"/>
  <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell cultureAntimicrobial agents Chemother201458487584 26.CaoBWangYWenDLiuWWangJFanGet al.A"/>
  <result pre="Chemother201458487584 26.CaoBWangYWenDLiuWWangJFanGet al.A Trial of Lopinavir-Ritonavir in Adults Hospitalized with" exact="Severe" post="Covid-19N Engl J Med202038217879932187464 27.Chen C, Zhang Y, Huang"/>
  <result pre="effectiveness of aerosolized versus oral ribavirin for the treatment of" exact="respiratory" post="syncytial virus infections: a single-center retrospective cohort study and"/>
  <result pre="role of ribavirinJ Hepatol2016642152526409316 31.LeeNHuiDWuAChanPCameronPJoyntGMet al.A major outbreak of severe" exact="acute" post="respiratory syndrome in Hong KongN Engl J Med200334819869412682352 32.BoothCMMatukasLMTomlinsonGARachlisARRoseDBDwoshHAet"/>
  <result pre="of ribavirinJ Hepatol2016642152526409316 31.LeeNHuiDWuAChanPCameronPJoyntGMet al.A major outbreak of severe acute" exact="respiratory" post="syndrome in Hong KongN Engl J Med200334819869412682352 32.BoothCMMatukasLMTomlinsonGARachlisARRoseDBDwoshHAet al.Clinical"/>
  <result pre="ribavirinJ Hepatol2016642152526409316 31.LeeNHuiDWuAChanPCameronPJoyntGMet al.A major outbreak of severe acute respiratory" exact="syndrome" post="in Hong KongN Engl J Med200334819869412682352 32.BoothCMMatukasLMTomlinsonGARachlisARRoseDBDwoshHAet al.Clinical features"/>
  <result pre="risk factors for adverse clinical outcomes in adults with severe" exact="acute" post="respiratory syndrome (SARS)Thorax200358686912885985 34.SungJJYWuAJoyntGMYuenKYLeeNChanPKSet al.Severe acute respiratory syndrome: report"/>
  <result pre="factors for adverse clinical outcomes in adults with severe acute" exact="respiratory" post="syndrome (SARS)Thorax200358686912885985 34.SungJJYWuAJoyntGMYuenKYLeeNChanPKSet al.Severe acute respiratory syndrome: report of"/>
  <result pre="for adverse clinical outcomes in adults with severe acute respiratory" exact="syndrome" post="(SARS)Thorax200358686912885985 34.SungJJYWuAJoyntGMYuenKYLeeNChanPKSet al.Severe acute respiratory syndrome: report of treatment"/>
  <result pre="in adults with severe acute respiratory syndrome (SARS)Thorax200358686912885985 34.SungJJYWuAJoyntGMYuenKYLeeNChanPKSet al.Severe" exact="acute" post="respiratory syndrome: report of treatment and outcome after a"/>
  <result pre="adults with severe acute respiratory syndrome (SARS)Thorax200358686912885985 34.SungJJYWuAJoyntGMYuenKYLeeNChanPKSet al.Severe acute" exact="respiratory" post="syndrome: report of treatment and outcome after a major"/>
  <result pre="Commun2005326905815607755 36.OmraniASSaadMMBaigKBahloulAAbdul-MatinMAlaidaroosAYet al.Ribavirin and interferon alfa-2a for severe Middle East" exact="respiratory" post="syndrome coronavirus infection: a retrospective cohort studyLancet Infect Dis2014141090525278221"/>
  <result pre="36.OmraniASSaadMMBaigKBahloulAAbdul-MatinMAlaidaroosAYet al.Ribavirin and interferon alfa-2a for severe Middle East respiratory" exact="syndrome" post="coronavirus infection: a retrospective cohort studyLancet Infect Dis2014141090525278221 37.SavarinoAUse"/>
  <result pre="a retrospective cohort studyLancet Infect Dis2014141090525278221 37.SavarinoAUse of chloroquine in" exact="viral" post="diseasesLancet Infect Dis201111653421550312 38.SavarinoABoelaertJRCassoneAMajoriGCaudaREffects of chloroquine on viral infections:"/>
  <result pre="chloroquine in viral diseasesLancet Infect Dis201111653421550312 38.SavarinoABoelaertJRCassoneAMajoriGCaudaREffects of chloroquine on" exact="viral" post="infections: an old drug against todayâ€™s diseases?Lancet Infect Dis20033722714592603"/>
  <result pre="Virol2012862856822205743 41.VincentMJBergeronEBenjannetSEricksonBRRollinPEKsiazekTGet al.Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spreadVirol J200526916115318 42.Guangsheng Su XG. Progress in antiviral"/>
  <result pre="42.Guangsheng Su XG. Progress in antiviral therapy of new coronavirus" exact="pneumonia" post="[in Chinese]. Chinese Journal of Difficult and Complicated Cases"/>
  <result pre="new coronavirus pneumonia [in Chinese]. Chinese Journal of Difficult and" exact="Complicated" post="Cases 2020; http://kns.cnki.net/kcms/detail/13.1316.R.20200226.0918.002.html. 43.BlaisingJPolyakSJPÃ©cheurE-IArbidol as a broad-spectrum antiviral: an"/>
  <result pre="an updateAntivir Res2014107849424769245 44.BoriskinYSLenevaIAPÃ©cheurEIPolyakSJArbidol: a broad-spectrum antiviral compound that blocks" exact="viral" post="fusionCurr Med Chem.200815997100518393857 45.PÃ©cheurE-IBorisevichVHalfmannPMorreyJDSmeeDFPrichardMet al.The synthetic antiviral drug arbidol"/>
  <result pre="inhibitory effects of arbidol and Lianhuaqingwen Capsules on Middle East" exact="respiratory" post="syndrome coronavirus in vitro and in vivo[in Chinese]Guangdong Med"/>
  <result pre="effects of arbidol and Lianhuaqingwen Capsules on Middle East respiratory" exact="syndrome" post="coronavirus in vitro and in vivo[in Chinese]Guangdong Med J20183934548"/>
  <result pre="of arbidol and its derivatives against the pathogen of severe" exact="acute" post="respiratory syndrome in the cell cultures]Vopr Virusol200853913 48.https://www.chinanews.com/gn/2020/02-04/9078596.shtml. 49.WangZChenXLuYChenFZhangWClinical"/>
  <result pre="arbidol and its derivatives against the pathogen of severe acute" exact="respiratory" post="syndrome in the cell cultures]Vopr Virusol200853913 48.https://www.chinanews.com/gn/2020/02-04/9078596.shtml. 49.WangZChenXLuYChenFZhangWClinical characteristics"/>
  <result pre="and its derivatives against the pathogen of severe acute respiratory" exact="syndrome" post="in the cell cultures]Vopr Virusol200853913 48.https://www.chinanews.com/gn/2020/02-04/9078596.shtml. 49.WangZChenXLuYChenFZhangWClinical characteristics and"/>
  <result pre="and therapeutic procedure for four cases with 2019 novel coronavirus" exact="pneumonia" post="receiving combined Chinese and Western medicine treatmentBiosci Trends20201464832037389 50.De"/>
  <result pre="J.2019143962831389664 54.MulanguSDoddLEDaveyRTTshiani MbayaOProschanMMukadiDet al.A randomized, controlled trial of Ebola virus" exact="disease" post="therapeuticsN Engl J Med2019381229330331774950 55.CihlarTRayASNucleoside and nucleotide HIV reverse"/>
  <result pre="transcriptase inhibitors: 25 years after zidovudineAntivir Res201085395819887088 56.EltahlaAALucianiFWhitePALloydARBullRAInhibitors of the" exact="hepatitis C" post="virus polymerase; mode of action and resistanceViruses2015752062426426038 57.TchesnokovEPFengJYPorterDPGotteMMechanism of"/>
  <result pre="of Ebola virus RNA-dependent RNA polymerase by remdesivirViruses201911326 58.AgostiniMLAndresELSimsACGrahamRLSheahanTPLuXet al.Coronavirus" exact="susceptibility to" post="the antiviral remdesivir (GS-5734) is mediated by the viral"/>
  <result pre="susceptibility to the antiviral remdesivir (GS-5734) is mediated by the" exact="viral" post="polymerase and the proofreading exoribonucleasemBio20189e002211829511076 59.BrownAJWonJJGrahamRLDinnonKHSimsACFengJYet al.Broad spectrum antiviral"/>
  <result pre="and pharmacological properties of hydroxychloroquine and chloroquine in treatment of" exact="systemic" post="lupus erythematosus, rheumatoid arthritis and related diseasesInflammopharmacology2015232316926246395 64.BiotCDaherWChavainNFandeurTKhalifeJDiveDet al.Design"/>
  <result pre="pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic" exact="lupus erythematosus," post="rheumatoid arthritis and related diseasesInflammopharmacology2015232316926246395 64.BiotCDaherWChavainNFandeurTKhalifeJDiveDet al.Design and synthesis"/>
  <result pre="of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus," exact="rheumatoid arthritis" post="and related diseasesInflammopharmacology2015232316926246395 64.BiotCDaherWChavainNFandeurTKhalifeJDiveDet al.Design and synthesis of hydroxyferroquine"/>
  <result pre="hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid" exact="arthritis" post="and related diseasesInflammopharmacology2015232316926246395 64.BiotCDaherWChavainNFandeurTKhalifeJDiveDet al.Design and synthesis of hydroxyferroquine"/>
  <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;Â"/>
  <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;Â pii:"/>
  <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="Coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;Â pii: ciaa237."/>
  <result pre="pii: ciaa237. 10.1093/cid/ciaa237. 66.MarmorMFKellnerULaiTYYMellesRBMielerWFRecommendations on Screening for Chloroquine and Hydroxychloroquine" exact="Retinopathy" post="(2016 Revision)Ophthalmology201612313869426992838 67.Gautret P, Lagier JC, Parola P, Hoang"/>
  <result pre="of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced" exact="acute" post="exacerbation of chronic obstructive pulmonary diseaseBiomed Pharmacother202012110965231734578 70.DingYZengLLiRChenQZhouBChenQet al.The"/>
  <result pre="Capsule and oseltamivir in influenza A viral-induced acute exacerbation of" exact="chronic" post="obstructive pulmonary diseaseBiomed Pharmacother202012110965231734578 70.DingYZengLLiRChenQZhouBChenQet al.The Chinese prescription lianhuaqingwen"/>
  <result pre="oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive" exact="pulmonary" post="diseaseBiomed Pharmacother202012110965231734578 70.DingYZengLLiRChenQZhouBChenQet al.The Chinese prescription lianhuaqingwen capsule exerts"/>
  <result pre="prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of" exact="viral" post="propagation and impacts immune functionBMC Complement Alternat Med.201717130 71.MatsumotoYMatsuuraTAoyagiHMatsudaMHmweSSDateTet"/>
  <result pre="functionBMC Complement Alternat Med.201717130 71.MatsumotoYMatsuuraTAoyagiHMatsudaMHmweSSDateTet al.Antiviral activity of glycyrrhizin against" exact="hepatitis C" post="virus in vitroPLoS One20138e6899223874843 72.CinatlJMorgensternBBauerGChandraPRabenauHDoerrHWGlycyrrhizin, an active component of"/>
  <result pre="Cai HB. Retrospective clinical analysis on treatment of novel coronavirus-infected" exact="pneumonia" post="with traditional chinese medicine Lianhua Qingwen [in Chinese]. Chin"/>
  <result pre="observation on 63 cases of suspected cases of new Coronavirus" exact="pneumonia" post="treated by Chinese Medicine Lianhua Qingwen [in Chinese]. J"/>
  <result pre="selenium on immune responses to a live bivalent vaccine of" exact="Newcastle disease" post="virus and infectious bronchitis virus in chickensPoult Sci20199835485631220864 78.LanJGeJYuJShanSZhouHFanSet"/>
  <result pre="on immune responses to a live bivalent vaccine of Newcastle" exact="disease" post="virus and infectious bronchitis virus in chickensPoult Sci20199835485631220864 78.LanJGeJYuJShanSZhouHFanSet"/>
  <result pre="to a live bivalent vaccine of Newcastle disease virus and" exact="infectious" post="bronchitis virus in chickensPoult Sci20199835485631220864 78.LanJGeJYuJShanSZhouHFanSet al.Structure of the"/>
  <result pre="a live bivalent vaccine of Newcastle disease virus and infectious" exact="bronchitis" post="virus in chickensPoult Sci20199835485631220864 78.LanJGeJYuJShanSZhouHFanSet al.Structure of the SARS-CoV-2"/>
  <result pre="Shi K, Wan Y, Luo C, Aihara H, et al." exact="Structural" post="basis of receptor recognition by SARS-CoV-2. Nature. 2020; 10.1038/s41586-020-2179-y.Â"/>
  <result pre="the past: possible urgent prevention and treatment options for severe" exact="acute" post="respiratory infections caused by 2019-nCoVChembiochem202021730832022370 83.Ju J, Kumar S,"/>
  <result pre="past: possible urgent prevention and treatment options for severe acute" exact="respiratory" post="infections caused by 2019-nCoVChembiochem202021730832022370 83.Ju J, Kumar S, Li"/>
  <result pre="possible urgent prevention and treatment options for severe acute respiratory" exact="infections" post="caused by 2019-nCoVChembiochem202021730832022370 83.Ju J, Kumar S, Li X,"/>
  <result pre="X, Jockusch S, Russo JJ. Nucleotide analogues as inhibitors of" exact="viral" post="polymerases. bioRxiv 2020: 2020.01.30.927574. 84.HoffmannMKleine-WeberHSchroederSKrÃ¼gerNHerrlerTErichsenSet al.SARS-CoV-2 cell entry depends"/>
 </snippets>
</snippetsTree>
